These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21811911)
1. Synthesis, antiproliferative activity, acute toxicity and assessment of the antiandrogenic activities of new androstane derivatives. Dhingra N; Bhardwaj TR; Mehta N; Mukhopadhyay T; Kumar A; Kumar M Arch Pharm Res; 2011 Jul; 34(7):1055-63. PubMed ID: 21811911 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, antiproliferative, acute toxicity and assessment of antiandrogenic activities of some newly synthesized steroidal lactams. Dhingra N; Bhardwaj TR; Mehta N; Mukhopadhyay T; Kumar A; Kumar M Eur J Med Chem; 2010 Jun; 45(6):2229-36. PubMed ID: 20171759 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiandrogenic activity of some new 3-substituted androstano[17,16-c]-5'-aryl-pyrazoline and their derivatives. Amr Ael-G; Abdel-Latif NA; Abdalla MM Bioorg Med Chem; 2006 Jan; 14(2):373-84. PubMed ID: 16182532 [TBL] [Abstract][Full Text] [Related]
4. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model. Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line. Cortés-Benítez F; Cabeza M; Ramírez-Apan MT; Alvarez-Manrique B; Bratoeff E Eur J Med Chem; 2016 Oct; 121():737-746. PubMed ID: 27423983 [TBL] [Abstract][Full Text] [Related]
6. New steroidal derivatives synthesized using 3beta-hydroxyandrosten-17-one as starting material. Abd El-Latif NA; Abdulla MM; Amr Ael-G Acta Pharm; 2008 Mar; 58(1):43-59. PubMed ID: 18337207 [TBL] [Abstract][Full Text] [Related]
7. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of some androstene oximes and their O-alkylated derivatives. Acharya PC; Bansal R Arch Pharm (Weinheim); 2014 Mar; 347(3):193-9. PubMed ID: 24343881 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of p450 17 as a new strategy for the treatment of prostate cancer. Leroux F Curr Med Chem; 2005; 12(14):1623-9. PubMed ID: 16022662 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of methoxycarbonylpyrazolylandrostene derivatives, and their potential inhibitory effect on androgen biosynthesis and cell proliferation. Szabó N; Iványi Z; Szécsi M; Julesz J; Mernyák E; Huber J; Wölfling J; Minorics R; Zupkó I; Schneider G Steroids; 2015 Jun; 98():143-52. PubMed ID: 25804762 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic, necrotic, and antiproliferative activity of diosgenin and diosgenin glycosides on cervical cancer cells. Hernández-Vázquez JMV; López-Muñoz H; Escobar-Sánchez ML; Flores-Guzmán F; Weiss-Steider B; Hilario-Martínez JC; Sandoval-Ramírez J; Fernández-Herrera MA; Sánchez Sánchez L Eur J Pharmacol; 2020 Mar; 871():172942. PubMed ID: 31972180 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of new D-seco and D-homo androstane derivatives. Djurendić EA; Zavis MP; Sakac MN; Canadi JJ; Kojić VV; Bogdanović GM; Penov Gasi KM Steroids; 2009 Nov; 74(12):983-8. PubMed ID: 19646459 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro antiproliferative activity of novel androst-5-ene triazolyl and tetrazolyl derivatives. Kádár Z; Kovács D; Frank É; Schneider G; Huber J; Zupkó I; Bartók T; Wölfling J Molecules; 2011 Jun; 16(6):4786-806. PubMed ID: 21659965 [TBL] [Abstract][Full Text] [Related]
14. Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation. Roell D; Rösler TW; Degen S; Matusch R; Baniahmad A Chem Biol Drug Des; 2011 Jun; 77(6):450-9. PubMed ID: 21439024 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and biological studies of diosgenyl analogues. Huang B; Du D; Zhang R; Wu X; Xing Z; He Y; Huang W Bioorg Med Chem Lett; 2012 Dec; 22(24):7330-4. PubMed ID: 23153797 [TBL] [Abstract][Full Text] [Related]
16. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines. Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044 [TBL] [Abstract][Full Text] [Related]
17. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer. Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)benzylidene]androstene derivatives as potent cytotoxic agents. Bansal R; Guleria S Steroids; 2008 Dec; 73(14):1391-9. PubMed ID: 18694772 [TBL] [Abstract][Full Text] [Related]
19. Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A. Liu W; Zhou J; Geng G; Shi Q; Sauriol F; Wu JH J Med Chem; 2012 Jan; 55(2):971-5. PubMed ID: 22175694 [TBL] [Abstract][Full Text] [Related]